KENNETH MCCLAIN to Disease-Free Survival
This is a "connection" page, showing publications KENNETH MCCLAIN has written about Disease-Free Survival.
Connection Strength
0.185
-
Hydroxyurea: a new old therapy for Langerhans cell histiocytosis. Blood. 2016 11 17; 128(20):2462-2465.
Score: 0.107
-
A phase II trial using thalidomide for Langerhans cell histiocytosis. Pediatr Blood Cancer. 2007 Jan; 48(1):44-9.
Score: 0.054
-
Differentiating skin-limited and multisystem Langerhans cell histiocytosis. J Pediatr. 2014 Nov; 165(5):990-6.
Score: 0.023